Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial

Abstract Background Biannual mass azithromycin administration to preschool children reduces all-cause mortality, but the mechanism for the effect is not understood. Azithromycin has activity against malaria parasites, and malaria is a leading cause of child mortality in the Sahel. The effect of bian...

Full description

Bibliographic Details
Published in:	Malaria Journal
Main Authors:	Catherine E. Oldenburg, Abdou Amza, Gretchen Cooley, Boubacar Kadri, Beido Nassirou, Benjamin F. Arnold, Philip J. Rosenthal, Kieran S. O’Brien, Sheila K. West, Robin L. Bailey, Travis C. Porco, Jeremy D. Keenan, Thomas M. Lietman, Diana L. Martin
Format:	Article
Language:	English
Published:	BMC 2019-12-01
Subjects:	Malaria Azithromycin Niger Mass drug administration
Online Access:	https://doi.org/10.1186/s12936-019-3033-2

Similar Items

Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
by: Kieran S. O’Brien, et al.
Published: (2021-04-01)

Seroepidemiology of trachoma in a low prevalence region receiving annual mass azithromycin distribution in Maradi, Niger.
by: Abdou Amza, et al.
Published: (2024-12-01)

The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study
by: Evan M. Bloch, et al.
Published: (2019-08-01)

Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR)
by: Ahmed M. Arzika, et al.
Published: (2024-05-01)

Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR).
by: Ahmed M Arzika, et al.
Published: (2024-05-01)

Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial
by: Jeremy D Keenan, ProfMD, et al.
Published: (2020-02-01)

Biannual Administrations of Azithromycin and the Gastrointestinal Microbiome of Malawian Children: A Nested Cohort Study Within a Randomized Controlled Trial
by: David Chaima, et al.
Published: (2022-02-01)

Therapeutic study of rosacea by Azithromycin and Metronidazole
by: Naseer A. Al-harchan
Published: (2010-01-01)

AZITHROMYCIN IN THERAPY OF BACTERIAL RHINOSINUSITES
by: A. A. Krivopalov, et al.
Published: (2017-07-01)

Comparison of therapeutic effects of topical azithromycin versus topical azithromycin with systemic doxycycline on posterior blepharitis
by: Mohamed A. H Ibrahim, et al.
Published: (2023-01-01)

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma
by: Kevin Cyrus Hong, et al.
Published: (2009-07-01)

Azithromycin-Associated Choreoathetosis
by: J Gordon Millichap
Published: (2011-04-01)

Efficacy of azithromycin in the treatment of cutaneous leishmaniasis
by: Seyyed Mohammad Alavi (MD), et al.
Published: (2009-03-01)

Mass distribution of azithromycin to prevent under-five mortality in sub-Saharan Africa: Do the benefits outweigh the costs with regard to antimicrobial resistance?
by: Sodiq Inaolaji Yusuff, et al.
Published: (2022-08-01)

Efficacy and Safety of Combined Isotretinoin and Azithromycin for Treatment of Severe Nodulocystic Acne
by: Samer A. Dhaher, et al.
Published: (2016-12-01)

Efficacy of Azithromycin in Comparison with Metronidazole in the Treatment of Chronic Periodontitis
by: Jawna’a K Mammdoh
Published: (2011-04-01)

Azithromycin-resistant mph(A)-positive Salmonella enterica serovar Typhi in the United States
by: Kaitlin A. Tagg, et al.
Published: (2024-12-01)

Two poles of the anti-inflammatory action of azithromycin
by: E. N. Lazareva, et al.
Published: (2023-07-01)

Azithromycin in the Treatment of Community-acquired Pneumonia in Children
by: N. I. Zryachkin, et al.
Published: (2016-04-01)

Resistance genes of Neisseria gonorrhoeae to cefixime and azithromycin
by: Louisa Ivana Utami, et al.
Published: (2023-02-01)

Azithromycin resistant gonococci: a literature review
by: Awoke Derbie, et al.
Published: (2020-08-01)

Preparation and evaluation of azithromycin binary solid dispersions using various polyethylene glycols for the improvement of the drug solubility and dissolution rate
by: Ehsan Adeli

Antimicrobial Resistance and Mechanisms of Azithromycin Resistance in Nontyphoidal Salmonella Isolates in Taiwan, 2017 to 2018
by: Chien-Shun Chiou, et al.
Published: (2023-02-01)

Use of Ketamine Infusion and Azithromycin as an Adjunct Therapy in Severe Acute Bronchiolitis
by: Osman Yeşilbaş
Published: (2017-12-01)

Increase in veterinary prescriptions of azithromycin during the COVID-19 pandemic in Brazil
by: Fernando de Sá Del Fiol, et al.
Published: (2023-07-01)

Inhibiting inflammasome; the possible mechanisms of action of azithromycin against COVID-19?
by: Ali Saeedi-Boroujeni, et al.
Published: (2021-01-01)

Corticosteroid and Azithromycin in Idiopathic Granulomatous Mastitis
by: Marzieh Salehi, et al.
Published: (2017-01-01)

Azithromycin and the microbiota of cystic fibrosis sputum
by: Nicole Acosta, et al.
Published: (2021-03-01)

Determination of azithromycin heteroresistant Campylobacter jejuni in traveler’s diarrhea
by: Woradee Lurchachaiwong, et al.
Published: (2019-05-01)

Azithromycin and the Outcome of Treated COVID-19 Patients: A Hospital-Based Study
by: Elly Usman
Published: (2022-07-01)

The effect of erythromycin and clarithromycin versus azithromycin on serum valproate concentration
by: Muradi Albanji, et al.
Published: (2022-04-01)

Effect of Early Administration of Clarithromycin or Azithromycin on Symptoms of Pertussis in Infants
by: Alberto Eugenio Tozzi, et al.
Published: (2025-03-01)

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
by: Seung Won Ra, et al.
Published: (2017-05-01)

Concerns and Considerations Regarding Azithromycin Use by Physicians
by: Nimra Razaque Arain
Published: (2025-01-01)

The effect of azithromycin on sputum inflammatory markers in bronchiectasis
by: L. C. Terpstra, et al.
Published: (2023-04-01)

Formulation and physicochemical characterization of azithromycin-loaded cubosomes
by: Hoorieh Zaker, et al.
Published: (2023-01-01)

EFFICACY OF AZITHROMYCIN ON EXPERIMENTAL TOXOPLASMOSIS INFECTED MICE
by: GEHAN A. RASHED, et al.
Published: (2020-08-01)

Azithromycin Versus Co-trimoxazole in The Treatment of Doxycycline Resistant Acne Vulgaris In Iraqi Patients
by: Basman M. Fadheel
Published: (2013-04-01)

Azithromycin versus doxycycline for the treatment of urogenital Chlamydia trachomatis infection—a retrospective study
by: Ligang YANG, et al.
Published: (2021-06-01)

Effect of Azithromycin in Treatment of Cutaneous Leishmaniasis
by: Dindar Qurtas
Published: (2018-12-01)